267 related articles for article (PubMed ID: 3571978)
1. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
Flood PM; Schreiber H; Ron Y
J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
[TBL] [Abstract][Full Text] [Related]
2. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
[TBL] [Abstract][Full Text] [Related]
4. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
5. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
Hostetler LW; Romerdahl CA; Kripke ML
Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
LeGrue SJ; Simcik WJ; Frost P
Cancer Res; 1987 Aug; 47(16):4413-6. PubMed ID: 3607772
[TBL] [Abstract][Full Text] [Related]
7. Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
LeGrue SJ; Ananthaswamy HN; Simcik WJ
Cancer Res; 1989 Sep; 49(17):4747-51. PubMed ID: 2474372
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
9. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
10. Contrasuppression and tumor rejection.
Flood PM; Friedman A; Horvat B; Reuter P; Rodriquez A; Ptak W
Immunol Lett; 1987 Dec; 16(3-4):297-303. PubMed ID: 2895064
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H
Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981
[TBL] [Abstract][Full Text] [Related]
12. Pecking order among tumor-specific antigens.
Urban JL; Van Waes C; Schreiber H
Eur J Immunol; 1984 Feb; 14(2):181-7. PubMed ID: 6230244
[TBL] [Abstract][Full Text] [Related]
13. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
15. Role of helper T-lymphocytes in rejection of UV-induced murine skin cancers.
Romerdahl CA; Kripke ML
Cancer Res; 1988 May; 48(9):2325-8. PubMed ID: 2965612
[TBL] [Abstract][Full Text] [Related]
16. Generation of anti-hapten T cell cytotoxicity in vivo. Relationship to contact sensitivity and the role of contrasuppression.
Ptak W; Friedman AM; Flood PM
Arch Immunol Ther Exp (Warsz); 1994; 42(3):185-92. PubMed ID: 7487350
[TBL] [Abstract][Full Text] [Related]
17. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
[TBL] [Abstract][Full Text] [Related]
18. The specificity of concomitant tumor immunity at large tumor volumes.
Deckers PJ; Pardridge DH; Wang BS; Mannick JA
Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
[TBL] [Abstract][Full Text] [Related]
19. Dendritic epidermal T cells in ultraviolet-irradiated skin enhance skin tumor growth by inhibiting CD4+ T-cell-mediated immunity.
Cavanagh LL; Halliday GM
Cancer Res; 1996 Jun; 56(11):2607-15. PubMed ID: 8653705
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]